CYD Dengue Vaccine + Inactivated rabies virus vaccine + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Dengue Virus
Conditions
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever, Dengue Diseases
Trial Timeline
Feb 1, 2009 → Feb 1, 2014
NCT ID
NCT00842530About CYD Dengue Vaccine + Inactivated rabies virus vaccine + Placebo
CYD Dengue Vaccine + Inactivated rabies virus vaccine + Placebo is a phase 2 stage product being developed by Sanofi for Dengue Virus. The current trial status is completed. This product is registered under clinical trial identifier NCT00842530. Target conditions include Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00842530 | Phase 2 | Completed |
Competing Products
20 competing products in Dengue Virus